Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades

Korean Journal of Urology

Volumn 53, Issue 1, 2012, Pages 23-28

  Choi, Se Young ^a   Kim, Tae Hyoung ^a   Myung, Soon Chul ^a   Moon, Young Tae ^a   Kim, Kyung Do ^a   Kim, Young Sun ^a   Kim, Hye Ryoun ^a   Chang, In Ho ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Benign prostatic hyperplasia; Medical therapy; Surgical intervention

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ARTICLE; BODY MASS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HYPERTENSION; LASER PROSTATECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MINIMALLY INVASIVE SURGERY; ORGAN SIZE; ORGAN WEIGHT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROSTATE HYPERTROPHY; PROSTATE SURGERY; PROSTATECTOMY; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TREATMENT OUTCOME; URINE RETENTION;

EID: 84863068403     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2012.53.1.23     Document Type: Article

References (25)

1. Flanigan RC, Reda DJ, Wasson JH, Anderson RJ, Abdellatif M, Bruskewitz RC. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 1998;160:12-6.
2. Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006;49:970-8.
3. Chung BH, Yang KM, Hong SJ. Meta-analysis of alpha receptor antagosist for benign prostatic hyperplasia from papers that were published in Korea. Korean J Urol 2005;46:252-8.
4. Lepor H, Auerbach S, Puras-Baez A, Narayan P, Soloway M, Lowe F, et al. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 1992;148:1467-74.
5. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-98.
6. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132: 474-9.
7. Clifford GM, Farmer RD. Medical therapy for benign prostatic hyperplasia: a review of the literature. Eur Urol 2000;38:2-19.
8. Chang HS, Park CH, Kim CI. Comparison of the long term effect of alpha-blocker only and 5-alpha reductase inhibitor combination treatment on acute urinary retention and prostatic surgery for patients with benign prostatic hyperplasia. Korean J Urol 2006;47:7-12.
9. Izard J, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 2010;108:89-93.
10. Vela-Navarrete R, Gonzalez-Enguita C, Garcia-Cardoso JV, Manzarbeitia F, Sarasa-Corral JL, Granizo JJ. The impact of medical therapy on surgery for benign prostatic hyperplasia: a Korean J Urol 2012;53:23-28
11. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res 1997;5:542-8.
12. Barreto SM, Passos VM, Firmo JO, Guerra HL, Vidigal PG, Lima-Costa MF. Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil--The Bambui Health and Ageing Study. Arq Bras Cardiol 2001;77:576-81.
13. Han KS, Hong SJ, Chung BH. Changing trends in the management of bengin prostatic hyperplasia during recent 5 years. Korean J Urol 2005;46:458-62.
14. Shin YS, Park JK. Changes in surgical strategy for patients with benign prostatic hyperplasia: 12-year single-center experience. Korean J Urol 2011;52:189-93.
15. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008;180:246-9.
16. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7.
17. Starkman JS, Santucci RA. Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int 2005;95:69-71.
18. Saito M, Ohmura M, Kondo A. Restoration of rat bladder function following release of shortand long-term partial outflow obstruction. Urol Res 1997;25:193-7.
19. Boyle P, Roehrborn C, Harkaway R, Logie J, de la Rosette J, Emberton M. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol 2004;45:620-6.
20. Wasson JH, Bubolz TA, Lu-Yao GL, Walker-Corkery E, Hammond CS, Barry MJ. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol 2000;164:1212-5.
21. Borth CS, Beiko DT, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: a decade of change. Urology 2001;57:1082-5.
22. Kim TS, Choi S, Rhew HY, Ahn JH, Jang JH, Cho MH. Comparative study on the treatment outcome and safety of TURP, ILC, TUNA and TEAP for patients with benign prostatic hyperplasia. Korean J Urol 2006;47:13-9.
23. Kwon JS, Lee JW, Lee SW, Choi HY, Moon HS. Comparison of effectiveness of monopolar and bipolar transurethral resection of the prostate and open prostatectomy in large benign prostatic hyperplasia. Korean J Urol 2011;52:269-73.
24. Tan AH, Gilling PJ. Lasers in the treatment of benign prostatic hyperplasia: an update. Curr Opin Urol 2005;15:55-8.
25. Bhansali M, Patankar S, Dobhada S, Khaladkar S. Management of large (≥60 g) prostate gland: PlasmaKinetic Superpulse (bipolar) versus conventional (monopolar) transurethral resection of the prostate. J Endourol 2009;23:141-5.